Responses
Regular and young investigator award abstracts
Clinical trials completed
281 JAVELIN Medley VEGF: phase 2 study of avelumab + axitinib in patients with previously treated non-small cell lung cancer (NSCLC) or treatment naive, cisplatin-ineligible urothelial cancer (UC)
Compose a Response to This Article
Other responses
No responses have been published for this article.